-
摘要: 膀胱癌是一种常见的泌尿系恶性肿瘤，其中非肌层浸润性膀胱癌(NMIBC)占膀胱癌的75%~85%，病理类型以尿路上皮癌为主。经尿道膀胱肿瘤电切术(TURBT)辅以术后膀胱灌注化疗是NMIBC的标准治疗方法。然而常规使用吉西他滨、吡柔比星等化疗药物或是卡介苗进行灌注，会有较高的复发率，甚至进展至肌层浸润性膀胱癌。为了改变这一现状，研究者探索和研究了多种新的治疗方法。膀胱热灌注化疗(CHT)经历了近20年的临床试验和研究，被发现其能显著降低NMIBC术后复发的风险，相信在后续更深入更系统的研究后，会为NMIBC患者带来极大的获益。Abstract: Bladder cancer is a common malignant tumor of the urinary system, of which non-muscular invasive bladder cancer (NMIBC) accounts for 75%-85%, and the vital pathological type is urothelial carcinoma. Transurethral resection of bladder tumor (TURBT) combined with postoperative intravesical chemotherapy is the standard treatment for NMIBC. However, routine use of chemotherapy drugs such as gemcitabine and pirarubicin or BCG has a high recurrence rate and even progresses to muscle-invasive bladder cancer. In order to change this situation, a variety of new treatment methods have been explored and studied. Chemohyperthermia (CHT) has undergone nearly two decades of clinical trials and studies. It has been found that it can significantly reduce the risk of postoperative recurrence and progression of NMIBC. It is believed that subsequent more in-depth and systematic research will bring great benefits to NMIBC patients.
-
-
[1] 程波, 张海芳, 牛凌卫. P-gp、MRP及CD44在膀胱癌组织中的表达及与预后的关系研究[J]. 临床泌尿外科杂志, 2020, 35(4): 291-296. doi: 10.13201/j.issn.1001-1420.2020.04.008
[2] Campodonico F, Di Stasi S, Lev GM, et al. Intravesical chemotherapy and chemohyperthermia in non-muscle-invasive bladder cancer; an overview on drug administration technologies and pharmacokinetics[J]. Curr Drug Metab, 2017, 18(7): 657-665.
[3] Merten R, Ott O, Haderlein M, et al. Long-term experience of chemoradiotherapy combined with deep regional hyperthermia for organ preservation in high-risk bladder cancer(Ta, Tis, T1, T2)[J]. Oncologist, 2019, 24(12): e1341-e1350. doi: 10.1634/theoncologist.2018-0280
[4] van der Heijden AG, Verhaegh G, Jansen CF, et al. Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study[J]. J Urol, 2005, 173(4): 1375-1380. doi: 10.1097/01.ju.0000146274.85012.e1
[5] Rampersaud EN, Vujaskovic Z, Inman BA. Hyperthermia as a treatment for bladder cancer[J]. Oncology(Williston Park), 2010, 24(12): 1149-1155.
[6] Soria F, Allasia M, Oderda M, et al. Hyperthermia for non-muscle invasive bladder cancer[J]. Expert Rev Anticancer Ther, 2016, 16(3): 313-321. doi: 10.1586/14737140.2016.1135743
[7] Tan WP, Longo TA, Inman BA. Heated intravesical chemotherapy: biology and clinical utility[J]. Urol Clin North Am, 2020, 47(1): 55-72. doi: 10.1016/j.ucl.2019.09.008
[8] Arends TJ, Falke J, Lammers RJ, et al. Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia[J]. World J Urol, 2015, 33(10): 1411-1417. doi: 10.1007/s00345-014-1458-3
[9] Yuan Y, Cheng KS, Craciunescu OI, et al. Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma[J]. Med Phys, 2012, 39(3): 1170-1181. doi: 10.1118/1.3679839
[10] Inman BA, Stauffer PR, Craciunescu OA, et al. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer[J]. Int J Hyperthermia, 2014, 30(3): 171-175. doi: 10.3109/02656736.2014.882021
[11] Juang T, Stauffer PR, Craciunescu OA, et al. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer[J]. Int J Hyperthermia, 2014, 30(3): 176-183. doi: 10.3109/02656736.2014.898338
[12] Sousa A, Inman BA, Piñeiro I, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy(HIVEC)for treating intermediate and high-risk non-muscle invasive bladder cancer[J]. Int J Hyperthermia, 2014, 30(3): 166-170. doi: 10.3109/02656736.2014.900194
[13] Babjuk M, Burger M, Compe 'rat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer(TaT1 and Carcinoma InSitu)-2019 Update[J]. Eur Urol, 2019, 76(5): 639-657. doi: 10.1016/j.eururo.2019.08.016
[14] Coenen J, van Valenberg F, Arends T, et al. Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives[J]. Arch Esp Urol, 2018, 71(4): 400-408.
[15] Tan WS, Panchal A, Buckley L, et al. Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy(HYMN): A Phase Ⅲ, Open-label, Randomised Controlled Trial[J]. Eur Urol, 2019, 75(1): 63-71. doi: 10.1016/j.eururo.2018.09.005
[16] Tan WP, Chang A, Brousell SC, et al. Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study[J]. Int J Hyperthermia, 2020, 37(1): 854-860. doi: 10.1080/02656736.2020.1780328
[17] 刘建萍, 龚志勇. 卡介苗膀胱灌注新进展[J]. 临床泌尿外科杂志, 2020, 35(11): 933-938. doi: 10.13201/j.issn.1001-1420.2020.11.019
[18] 付云峰. 经尿道膀胱肿瘤电切术后膀胱热灌注化疗治疗非肌层浸润性膀胱癌患者的回顾性研究[J]. 国际医药卫生导报, 2020, 26(13): 1944-1946. doi: 10.3760/cma.j.issn.1007-1245.2020.13.036
[19] 李靖, 王斌, 张震, 等. 膀胱灌注流量及膀胱充盈程度在膀胱热灌注化疗中的应用[J]. 实用医学杂志, 2020, 36(15): 2167-2169. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202015031.htm
[20] Maffezzini M, Campodonico F, Canepa G, et al. Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer(EORTC)score risk of recurrence and progression[J]. Cancer Chemother Pharmacol, 2014, 73(5): 925-930. doi: 10.1007/s00280-014-2423-y
[21] Arends TJH, van der Heijden AG, Witjes JA. Combined chemohyperthermia: the 10-years monocentric experience in 160 non-muscle invasive bladder cancer patients[J]. J Urol, 2014, 192: 708-713. doi: 10.1016/j.juro.2014.03.101
[22] Craciunescu OI, Stauffer PR, Soher BJ, et al. Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas[J]. Med Phys, 2009, 36(11): 4848-4858. doi: 10.1118/1.3227506
[23] Colombo R, Da Pozzo LF, Salonia A, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma[J]. J Clin Oncol, 2003, 21(23): 4270-4276. doi: 10.1200/JCO.2003.01.089
[24] Colombo R, Salonia A, Leib Z, et al. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer(NMIBC)[J]. BJU Int, 2011, 107(6): 912-918. doi: 10.1111/j.1464-410X.2010.09654.x
[25] Park J, Song C, Hong JH, et al. Prognostic significance of non-papillary tumor morphology as a predictor of cancer progression and survival in patients with primary T1G3 bladder cancer[J]. World J Urol, 2009, 27(2): 277-283. doi: 10.1007/s00345-008-0350-4
[26] Zhou J, Li L, Li X, et al. Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate-and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial[J]. Int J Hyperthermia, 2019, 36(1): 868-875.
[27] 王俞, 李煜罡, 洪健, 等. BR-TRG-Ⅰ型体腔热灌注治疗仪实施膀胱热灌注化疗的临床观察[J]. 临床肿瘤学杂志, 2017, 22(9): 831-834. doi: 10.3969/j.issn.1009-0460.2017.09.013
[28] 魏俊峰. 膀胱热灌注化疗联合经尿道电切术治疗非肌层浸润型膀胱癌患者的临床观察[J]. 现代诊断与治疗, 2021, 32(8): 1273-1274. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD202108047.htm
[29] 林洋. 吡柔比星膀胱热灌注联合经尿道膀胱肿瘤电切术对非肌层浸润性膀胱癌患者术后细胞因子水平及复发率的影响[J]. 中国药物与临床, 2021, 21(22): 3727-3730. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC202122033.htm
[30] 李靖, 王斌, 陈彦飞, 等. 膀胱热灌注化疗中导尿管型号的选择[J]. 国际医药卫生导报, 2021, 27(24): 3805-3809. doi: 10.3760/cma.j.issn.1007-1245.2021.24.014
[31] 李靖, 王斌, 陈彦飞. 膀胱热灌注化疗与普通膀胱灌注化疗患者的生命质量比较[J]. 河南外科学杂志, 2022, 28(1): 1-4. https://www.cnki.com.cn/Article/CJFDTOTAL-HLWK202201001.htm
[32] 李伟, 刘昊. 铜绿假单胞菌注射液膀胱灌注预防非肌层浸润性膀胱癌术后复发的有效性及对患者生活质量和血清VEGF的影响[J]. 临床泌尿外科杂志, 2020, 35(2): 133-136. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202002011.htm
-
计量
- 文章访问数: 1639
- PDF下载数: 918
- 施引文献: 0
下载: